Sir Philip Cohen, Director of the Medical Research Council Protein Phosphorylation Unit, has been awarded the prestigious 2006 Rolf Luft Award, which he received on October 3rd, in Stockholm, Sweden.
The Prize was created in 2000 in honour of Rolf Luft, Sweden's most famous endocrinologist, and is awarded by the Karolinska Institute.
Sir Philip was awarded the Prize for his ground-breaking research into the role of Protein Phosphorylation in Cell Regulation and Human Disease, especially his contributions to the understanding of how insulin regulates glucose metabolism and the implications of this research for the development of improved drugs to treat Diabetes.
Commenting on the award, Sir Philip expressed his surprise at receiving the honour. 'Usually an award like this does not come as a total surprise because one knows that someone has put you forward for the prize. However, on this occasion I had no idea that I had even been nominated and still have no idea who proposed me.
'Nevertheless, it is a great honour to have received this award which I am happy to receive on behalf of the many postdoctoral researchers and Ph.D. students who helped me to understand insulin's mode of action between the years 1973 and 1997.'
Previous winners of the award include Jeffrey Friedman of the Rockefeller University, New York, for the discovery of the appetite-controlling hormone leptin, Ronald Kahn, the Director of the Joslin Diabetes Institute, Boston, Massachusetts, for discovering the biological activity of the insulin receptor and Steven O'Rahilly, Department of Clinical Biochemistry of University of Cambridge, UK, for the identifying genes that control obesity.
Born in Stockholm in 1914, Rolf Luft made many seminal discoveries in the field of endocrinology. These included solving the problem of where androgens are made and how a lack of these hormones causes Addison's disease, the discovery of the beneficial effect of the hormone ACTH for the treatment of rheumatoid arthritis, and the discovery of the first disease of energy production, now called Luft's disease.
Aged 92 and still in good health, Rolf Luft attended the Award Ceremony and Philip's lecture which was entitled 'From insulin signalling to the regulation of cytokine production by pathogens.'
The Prize was created in 2000 in honour of Rolf Luft, Sweden's most famous endocrinologist, and is awarded by the Karolinska Institute.
Sir Philip was awarded the Prize for his ground-breaking research into the role of Protein Phosphorylation in Cell Regulation and Human Disease, especially his contributions to the understanding of how insulin regulates glucose metabolism and the implications of this research for the development of improved drugs to treat Diabetes.
Commenting on the award, Sir Philip expressed his surprise at receiving the honour. 'Usually an award like this does not come as a total surprise because one knows that someone has put you forward for the prize. However, on this occasion I had no idea that I had even been nominated and still have no idea who proposed me.
'Nevertheless, it is a great honour to have received this award which I am happy to receive on behalf of the many postdoctoral researchers and Ph.D. students who helped me to understand insulin's mode of action between the years 1973 and 1997.'
Previous winners of the award include Jeffrey Friedman of the Rockefeller University, New York, for the discovery of the appetite-controlling hormone leptin, Ronald Kahn, the Director of the Joslin Diabetes Institute, Boston, Massachusetts, for discovering the biological activity of the insulin receptor and Steven O'Rahilly, Department of Clinical Biochemistry of University of Cambridge, UK, for the identifying genes that control obesity.
Born in Stockholm in 1914, Rolf Luft made many seminal discoveries in the field of endocrinology. These included solving the problem of where androgens are made and how a lack of these hormones causes Addison's disease, the discovery of the beneficial effect of the hormone ACTH for the treatment of rheumatoid arthritis, and the discovery of the first disease of energy production, now called Luft's disease.
Aged 92 and still in good health, Rolf Luft attended the Award Ceremony and Philip's lecture which was entitled 'From insulin signalling to the regulation of cytokine production by pathogens.'